This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations in Cancer Treatment by Thomas M. Wilkie
Introduction
Thomas M. Wilkie is an accomplished inventor based in Dallas, TX (US). He has made significant contributions to the field of cancer research, particularly in the treatment of pancreatic ductal adenocarcinoma (PDA). His innovative approaches aim to improve therapeutic outcomes for patients suffering from this aggressive form of cancer.
Latest Patents
Wilkie holds a patent for a method titled "Screen and use of therapeutics for pancreatic ductal adenocarcinoma." This patent describes methods for screening compounds that can treat PDA using a mouse model with an Rgs16::GFP reporter. Additionally, it outlines combination therapies that utilize taxanes, gemcitabine, and an Axl kinase inhibitor to enhance treatment efficacy.
Career Highlights
Wilkie is affiliated with the University of Texas System, where he continues to advance his research in cancer therapeutics. His work is characterized by a commitment to developing innovative solutions that address critical health challenges.
Collaborations
One of his notable collaborators is Rolf A. Brekken, with whom he has worked to further the understanding and treatment of pancreatic cancer.
Conclusion
Thomas M. Wilkie's contributions to cancer research exemplify the impact of innovative thinking in medicine. His patent for treating pancreatic ductal adenocarcinoma represents a significant step forward in the fight against this challenging disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile